Interleukin Genetics, Inc. is a genetics-based personalized health company that develops genetic tests for use in the emerging personalized health market. Our vision is to build a leading personalized health and wellness company. We believe that the science of applied genetics can empower physicians and dentists to improve management of chronic diseases, and empower individuals to personalize their own health. In some diseases, such as osteoarthritis, our tests provide valuable information to assist in drug development. We currently have two primary focus areas to our business.

The first is personalized health, which is focused on providing genetic information to physicians, dentists, and in some cases consumers.
The second is a research and development effort focused on developing genetic tests linked to a partner’s products for marketing and sales into medical and dental channels.
Both areas contribute toward our overall mission of providing products that can help individuals improve and maintain their health through preventive measures. We plan to pursue improving personalized healthcare for patients by:

processing genetic risk assessment tests in our CLIA-certified lab or in labs of sub licensees for ourselves or for partners; and
distributing existing and developing new genetic tests for use in multiple indications, countries and demographics.